HALMED invites all general practitioners, pharmacists and cardiologists to participate in the survey on HCPs' opinions and views on safety communications
The Agency for Medicinal Products and Medical Devices (HALMED) in collaboration with Croatian Society of Family Physicians (HDOD), Croatian Pharmaceutical Society (HFD) and Croatian Cardiac Society (HKD) has initiated a survey on views of healthcare professionals on how competent authorities, like HALMED in Croatia, communicate new safety issues related to use of medicines to healthcare professionals.
The survey is part of a broader pharmacovigilance EU project entitled SCOPE (Strengthening Collaboration for Operating Pharmacovigilance in Europe) aimed at improving the health safety of patients in the EU, by promoting co-operation among member states and providing support to medicines regulatory agencies in meeting the requirements of the EU pharmacovigilance legislation. The results of the survey will be used for optimisation of risk communication by medicines regulatory agencies at the EU level.
As a result of HALMED’s efforts, the Republic of Croatia has been chosen among other Member States to participate in conducting this survey within the SCOPE aimed at providing a possibility to healthcare professionals to express their opinions and views on safety communications. Other participating countries are Spain, United Kingdom, Ireland, Italy, Sweden, the Netherlands, Norway and Denmark.
In line with the settings of the SCOPE project, HALMED invites all general practitioners, pharmacists and cardiologists to participate in the survey as target groups.
The aim of communicating safety information to healthcare professionals is to contribute to protecting public health by promoting rational, safe and effective use of medicines and preventing harm from adverse reactions.
The survey will be used to investigate experiences of general practitioners, pharmacists and cardiologists with safety communication by the medicines regulatory agencies, as well as their views on effectiveness of this communication and preferred channels for communicating the safety issues on medicines.
The survey consists of questions on three specific types of safety communications used by competent authorities:
- Dear Healthcare Professionals Letters,
- National regulatory agency communications (e.g. via Newsletter),
- Educational materials.